Insider · CIK 0001591245

Langren Carl W.

Reports to the SEC for 1 company · AMES, IA

sec.gov

Transactions

Companies

Filings

CIK

0001591245

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−683 sh	$12.25	−$8,366.75	11,494
2021-02-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+939 sh	—	—	12,177
2021-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+11.5K sh	—	—	11,475
2020-04-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+9,000 sh	—	—	11,238
2020-04-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2020-01-04	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−281 sh	$2.21	−$621.01	20,144
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,380 sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+1,190 sh	—	—	1,190
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−16.7K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+8,333 sh	—	—	8,333
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−23.8K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+11.7K sh	—	—	11,719
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,211 sh	—	—	2,211
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+4,821 sh	—	—	4,821
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−55K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+4,583 sh	—	—	4,583
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+4,870 sh	—	—	4,870
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+4,297 sh	—	—	4,297
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,438 sh	—	—	3,438
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,438 sh	—	—	3,438
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,293 sh	—	—	2,293
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,291 sh	—	—	2,291
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,291 sh	—	—	2,291
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−100K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+11.5K sh	—	—	11,458
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+24.3K sh	—	—	24,250
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+14.3K sh	—	—	14,293
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+9,038 sh	—	—	9,038
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,867 sh	—	—	2,867
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−15K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+5,472 sh	—	—	5,472
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,028 sh	—	—	2,028
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−20K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,539 sh	—	—	3,539
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,129 sh	—	—	3,129
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−27K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+6,692 sh	—	—	6,692
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+2,309 sh	—	—	2,309
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−16.3K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,487 sh	—	—	3,487
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+589 sh	—	—	589
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−8,989 sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+1,639 sh	—	—	1,639
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+328 sh	—	—	328
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+281 sh	—	—	281
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−20K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+9,392 sh	—	—	9,392
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+278 sh	—	—	278
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+330 sh	—	—	330

Recent filings

Accepted (ET)
Apr 54
Langren Carl W.0001126234-21-000043
SEC(opens sec.gov)
Feb 34
Langren Carl W.0001126234-21-000009
SEC(opens sec.gov)
Apr 34
Langren Carl W.0001126234-20-000046
SEC(opens sec.gov)
Jan 64
Langren Carl W.0001126234-20-000005
SEC(opens sec.gov)
Aug 24
Langren Carl W.0001126234-19-000102
SEC(opens sec.gov)
Aug 24
Langren Carl W.0001126234-19-000103
SEC(opens sec.gov)

Companies

LUMOS PHARMA, INC.Chief Financial Officer

Address

C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR., SUITE 5100

AMES, IA, 50010